Sign-up for Newark Prep Charter School Students to Ring Opening Bell at New York Stock Exchange; Ring in Start of National School Choice Week 2015 with Andrew Campanella, K12 Inc., and Other School Choice Leaders investment picks
HARMAN, the premium global audio, visual, infotainment and enterprise
automation group (NYSE:HAR), today unveiled the world’s first
aftermarket amplifiers to feature HARMAN’s Clari-Fi technology, a
proprietary software solution capable of analyzing and improving sound
quality of compressed, digital music sources in real-time.
Sign-up for Navios Maritime Holdings Inc. Declares Quarterly Dividend of $54.6875 per Share on Its Series G Preferred Stock; Quarterly Dividend of $53.90625 per Share on Its Series H Preferred Stock investment picks
Sign-up for Lifshitz & Miller Law Firm Announces Investigation of DaVita HealthCare Partners Inc., JPS Industries, Inc., Meadowbrook Insurance Group, Inc., Medbox, Inc., State Investors Bancorp, Inc. and Uranerz Energy Corporation investment picks
NRG Yield, Inc. (NYSE:NYLD) (“NRG Yield”) today announced that it
intends to file a registration statement on Form S-3 (the “Registration
Statement”) with the Securities and Exchange Commission (the
“Commission”) on or about January 16, 2015, for the resale of NRG
Yield's Class A common stock, par value $0.01 per share (the
“Registrable Securities”), which may, under certain circumstances, be
issued upon conversion of its outstanding 3.50% Convertible Senior Notes
due 2019 (the “Notes”).
The Notes were originally sold to qualified institutional buyers by
means of a private placement in accordance with Rule 144A under the
Securities Act of 1933, as amended, on February 11, 2014 and March 3,
2014; at the same time a Registration Rights Agreement (the
“Registration Rights Agreement”) was entered into between NRG Yield and
the initial purchasers of the Notes, which
Select Income REIT (NYSE: SIR) today announced that its Board of
Trustees has declared a prorated common share distribution, conditioned
upon the completion of the pending merger with Cole Corporate Income
Trust, Inc. (CCIT). The prorated distribution is intended to align the
two companies’ distributions for the first quarter of 2015.
By Philip van Doorn, MarketWatch
Defensive sectors are leading the market, with energy and financials lagging
After yet another year of gains for the S&P 500 Index, it's been a drab January for investors.
Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today early study findings demonstrating an overall response
rate of 18.5 percent with KEYTRUDA, the company’s anti-PD-1 therapy, as
assessed by RECIST v1.1, central review (n=5/27), in PD-L1 positive,
advanced triple-negative breast cancer – one of the most aggressive
forms of breast cancer.
Sign-up for Data Investigating KEYTRUDA® (pembrolizumab), Merck’s Anti-PD-1 Therapy, in Patients with Advanced Triple-Negative Breast Cancer Presented at 2014 San Antonio Breast Cancer Symposium investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.